Serum Uric Acid and C-reactive Protein in Patients with Metastatic Colorectal Carcinoma During Combination Therapy with High-dose Folinic Acid
New spectrum of side effects has emerged with the introduction of targeted therapies, including changes in parameters determining cardiovascular risk. Among other laboratory parameters, hyperuricemia and elevated Creactive protein (CRP) are associated with increased risk of cardiovascular disease. T...
Main Authors: | Melichar Bohuslav, Hyšpler Radomír, Kalábová Hana, Holecková Petra, Študentová Hana |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2012-02-01
|
Series: | Pteridines |
Subjects: | |
Online Access: | https://doi.org/10.1515/pteridines.2012.23.1.8 |
Similar Items
-
Association of peripheral blood cell count-derived ratios, biomarkers of inflammatory response and tumor growth with outcome in previously treated metastatic colorectal carcinoma patients receiving cetuximab
by: Melichar Bohuslav, et al.
Published: (2017-12-01) -
Gastrointestinal Permeability - a Parameter of Possible Prognostic Importance in Metastatic Colorectal Carcinoma
by: Melichar Bohuslav, et al.
Published: (2008-02-01) -
Prognostic signature of colorectal cancer based on uric acid-related genes
by: Chun Zhuang, et al.
Published: (2023-12-01) -
Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01) -
Efficacy of Liver Chemoembolization after Prior Cetuximab Monotherapy in Patients with Metastatic Colorectal Cancer
by: Marcin Szemitko, et al.
Published: (2023-01-01)